Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study
| Image |  |
|---|---|
| Description | scientific article published on 22 March 2019 |
| Author/s |
author: Sudha Visvanathan Brygida Kwiatkowska |
| Publication date | March 22, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |